George Lamprinidis

19PUBLICATIONS
44CO-AUTHORS
PharmacogenomicsMolecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 30, 2026
Structure-Based Design of Covalent SARS-CoV‑2 Main Protease Inhibitors Targeting the Nirmatrelvir-Resistant E166 Mutants.

Zhengjun Cai, Navita Kohaal, Kyriakos Georgiou

|Jan 28, 2026
Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation".

Filippos Panteleimon Chatzipieris, Errikos Petsas, George Lambrinidis

|Jan 28, 2026
Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).

Filippos Panteleimon Chatzipieris, Errikos Petsas, George Lambrinidis

|Jan 25, 2025
Towards New Scaffolds for Antimicrobial Activity-In Silico/In Vitro Workflow Introducing New Lead Compounds.

Maria Mangana, George Lambrinidis, Ioannis K Kostakis

|Nov 20, 2024
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer.

Christos Liolios, Danai Bouziotis, Wiebke Sihver

|Jul 29, 2024
Hit-to-Lead Optimization of Heterocyclic Carbonyloxycarboximidamides as Selective Antagonists at Human Adenosine A3 Receptor.

Xianglin Huang, Anna Chorianopoulou, Panagoula Kalkounou

Pageof 4

Frequent Collaborators

7 joint publications

Antonios Kolocouris

4 joint publications

Emmanuel Mikros

3 joint publications

Jun Wang

2 joint publications

Errikos Petsas